What's New :
UPSC Interview Guidance Program. Register here...

India’s first mRNA based Omicron-specific booster vaccine

  • Category
    Science & Technology
  • Published
    23rd Jun, 2023


India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM, developed by Pune-based Gennova Biopharmaceuticals Ltd, was approved under emergency use guidelines by the Drug Controller General of India.


  • The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant 
  • The vaccine is a lyophilised (freeze dried) vaccine, stable at two to eight degrees Centigrade.
  • The vaccines could be administered into the skin via a “needle-free” PharmaJet system.

What are mRNA vaccines?

  • The mRNA vaccines use mRNA’s function as a protein information carrier to prompt the body to make specific proteins.
    • In the case of COVID-19 vaccines, the mRNA instructs the cells to produce the spike protein found on the outside of the SARS-CoV-2 virus.
  • When the body’s immune system detects these foreign proteins, it produces antibodies and other immune cells to fight what looks like an infection.
  • Then, if the immune system encounters that protein again in the future, it’s primed to mount a rapid response.

About messenger RNA (mRNA)

  • Messenger RNA (mRNA) is a molecule that contains the instructions or recipe that directs the cells to make a protein using its natural machinery.

Verifying, please be patient.

Our Centers

DELHI (Karol Bagh)

GS SCORE, 1B, Second Floor, Pusa Road, Karol Bagh, New Delhi - 110005 (Beside Karol Bagh Metro Station Gate No. 8)

Get directions on Google Maps

BHUBANESWAR (Jaydev Vihar)

GS SCORE, Plot No.2298, Jaydev Vihar Square, Near HCG Day Care, BBSR - 751013

Get directions on Google Maps

LUCKNOW (Aliganj)

GS SCORE, 2nd Floor, B-33, Sangam Chauraha, Sector H, Aliganj, Lucknow, UP - 226024

Get directions on Google Maps

Enquire Now